Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, C.
Right arrow Articles by Waugh, D. J.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, C.
Right arrow Articles by Waugh, D. J.J.
Clinical Cancer Research Vol. 11, 4117-4127, June 1, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer

Catherine Murphy1, Maryalice McGurk1, Johanna Pettigrew1, Alfredo Santinelli2, Roberta Mazzucchelli2, Patrick G. Johnston1, Rodolfo Montironi2 and David J.J. Waugh1

Authors' Affiliations: 1 Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, Northern Ireland and 2 Section of Pathological Anatomy and Histopathology, Polytechnic University of the Marche Region (Ancona), Ancona, Italy

Requests for reprints: David J.J. Waugh, Centre for Cancer Research and Cell Biology, Queens University Belfast, University Floor, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, Northern Ireland. Phone: 44-2890-263911; Fax: 44-2890-263744; E-mail: d.waugh{at}qub.ac.uk.

Purpose: We characterized interleukin-8 (IL-8) and IL-8 receptor expression (CXCR1 and CXCR2) in prostate cancer to address their significance to this disease.

Experimental Design: Immunohistochemistry was conducted on 40 cases of human prostate biopsy containing histologically normal and neoplastic tissue, excised from patients with locally confined or invasive androgen-dependent prostate cancer, and 10 cases of transurethral resection of the prostate material from patients with androgen-independent disease.

Results: Weak to moderate IL-8 expression was strictly localized to the apical membrane of normal prostate epithelium. In contrast, membranous expression of IL-8, CXCR1, and CXCR2 was nonapical in cancer cells of Gleason pattern 3 and 4, whereas circumferential expression was present in Gleason pattern 5 and androgen-independent prostate cancer. Each of IL-8, CXCR1, and CXCR2 were also increasingly localized to the cytoplasm of cancer cells in correlation with advancing stage of disease. Cytoplasmic expression (but not apical membrane expression) of IL-8 in Gleason pattern 3 and 4 cancer correlated with Ki-67 expression (R = 0.79; P < 0.001), cyclin D1 expression (R = 0.79; P < 0.001), and microvessel density (R = 0.81; P < 0.001). In vitro studies on androgen-independent PC3 cells confirmed the mitogenic activity of IL-8, increasing the rate of cell proliferation through activation of both CXCR1 and CXCR2 receptors.

Conclusions: We propose that the concurrent increase in IL-8 and IL-8 receptor expression in human prostate cancer induces autocrine signaling that may be functionally significant in initiating and promoting the progression of prostate cancer by underpinning cell proliferation and angiogenesis.

Key Words: Interleukin-8 (IL-8) • Prostate Cancer • Angiogenesis • Proliferation • Metastasis




This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston, and D. J. J. Waugh
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Carcinogenesis, June 1, 2008; 29(6): 1148 - 1156.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. T. Mierke, D. P. Zitterbart, P. Kollmannsberger, C. Raupach, U. Schlotzer-Schrehardt, T. W. Goecke, J. Behrens, and B. Fabry
Breakdown of the Endothelial Barrier Function in Tumor Cell Transmigration
Biophys. J., April 1, 2008; 94(7): 2832 - 2846.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B.-R. Lin, C.-C. Chang, L.-R. Chen, M.-H. Wu, M.-Y. Wang, I-H. Kuo, C.-Y. Chu, K.-J. Chang, P.-H. Lee, W.-J. Chen, et al.
Cysteine-Rich 61 (CCN1) Enhances Chemotactic Migration, Transendothelial Cell Migration, and Intravasation by Concomitantly Up-Regulating Chemokine Receptor 1 and 2
Mol. Cancer Res., November 1, 2007; 5(11): 1111 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. W. Horton, Y. Yu, S. Zaja-Milatovic, R. M. Strieter, and A. Richmond
Opposing Roles of Murine Duffy Antigen Receptor for Chemokine and Murine CXC Chemokine Receptor-2 Receptors in Murine Melanoma Tumor Growth
Cancer Res., October 15, 2007; 67(20): 9791 - 9799.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Araki, Y. Omori, D. Lyn, R. K. Singh, D. M. Meinbach, Y. Sandman, V. B. Lokeshwar, and B. L. Lokeshwar
Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer
Cancer Res., July 15, 2007; 67(14): 6854 - 6862.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. F. MacManus, J. Pettigrew, A. Seaton, C. Wilson, P. J. Maxwell, S. Berlingeri, C. Purcell, M. McGurk, P. G. Johnston, and D. J.J. Waugh
Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells
Mol. Cancer Res., July 1, 2007; 5(7): 737 - 748.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Efstathiou, P. Troncoso, S. Wen, K.-A. Do, C. A. Pettaway, L. L. Pisters, T. J. McDonnell, and C. J. Logothetis
Initial Modulation of the Tumor Microenvironment Accounts for Thalidomide Activity in Prostate Cancer
Clin. Cancer Res., February 15, 2007; 13(4): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
F. BARBIERI, A. BAJETTO, C. PORCILE, A. PATTAROZZI, A. MASSA, G. LUNARDI, G. ZONA, A. DORCARATTO, J. L. RAVETTI, R. SPAZIANTE, et al.
CXC Receptor and Chemokine Expression in Human Meningioma: SDF1/CXCR4 Signaling Activates ERK1/2 and Stimulates Meningioma Cell Proliferation
Ann. N.Y. Acad. Sci., December 1, 2006; 1090(1): 332 - 343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Wislez, N. Fujimoto, J. G. Izzo, A. E. Hanna, D. D. Cody, R. R. Langley, H. Tang, M. D. Burdick, M. Sato, J. D. Minna, et al.
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.
Cancer Res., April 15, 2006; 66(8): 4198 - 4207.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.